Oncorad Group has opened a Nuclear Medicine Service at the Tanger Oncology Clinic in northern Morocco. The new unit improves cancer diagnosis and treatment by bringing advanced tools into one place.
The service is built to manage the full patient journey in one centre. Patients can now go from diagnosis to treatment and follow-up without moving between different facilities. It includes imaging for diagnosis, treatments such as radiotherapy, chemotherapy, robotic and surgical oncology procedures, brachytherapy, and transplant care. It also offers hospital beds, intensive care, and ongoing medical monitoring.
The centre includes three main technologies. A PET scan helps detect and track tumours at an early stage. A high-resolution gamma camera is used to spot small abnormalities. An Iratherapy unit includes two specially designed rooms for safe radiation-based cancer treatment, including iodine 131 therapy used for thyroid cancer.
A team of doctors, medical physicists, nurses, and technicians runs the service. All are trained to international standards.
Oncorad Group was created in 2000 by Professor Redouane Samlali and Dr Omar Hajji. It started as an oncology provider and has since expanded into a wider healthcare group. In 2023, it received investment from STOA and Cap Mezzanine 3, which supported its expansion.
Professor Samlali said: “to work toward the medicine of tomorrow and ensure it is accessible to all Moroccans.”
The group is also expanding nuclear medicine in other cities. In March, it carried out a combined PET scan and cryotherapy procedure in Casablanca. The method uses extreme cold to destroy tumours, guided by imaging.
During these procedures, doctors use live PET scans to check in real time that the tumour has been treated before the patient leaves the operating room. The group has also added artificial intelligence to its newest scanners to improve accuracy.
Its equipment includes high-sensitivity imaging cameras and specialised treatment rooms for iodine 131 therapy, mainly used for thyroid cancer. A new hospital has also been opened in Safi, expanding services in the Doukkala Abda region.
Oncorad’s growth has been supported by the 2023 investment, helping it increase its PET and CT scanning capacity. The nuclear medicine units work alongside other technologies such as the CyberKnife system, which adjusts radiotherapy to track tumour movement.
The group follows a model where diagnosis and treatment are combined in one place, with teams of surgeons, oncologists, and radiotherapy specialists working together.
